Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
スポンサーリンク
概要
- 論文の詳細を見る
The mechanism by which resistance to 1, 25 dihydroxyvitamin D3 (1, 25-(OH)2D3) occurs in patients with chronic renal failure was studied. This agent induces differentiation and 1, 25-(OH)2D3-24-hydroxylase activity in the mitochondria of the human promyelocytic leukemia cell line, HL-60, via a steroid-hormone receptor mechanism. HL-60 cells were cultured in RPMI 1640 medium supplemented with 10% normal or uremic serum. Treatment of these cells with 10-8M 1, 25-(OH)2D3 for 5 days in a medium containing 10% uremic serum from 4 patients with chronic renal failure resulted in a maturation of the cells amounting to 30.3 ± 18.7% (mean ± SD) and 32.5 ± 11.2%, as obtained by NBT reduction assay and NSE assay, respectively. These values were significantly lower than those obtained with 10% serum from 3 normal controls (66.6 ± 12.8%, 58.3 ± 10.9%, p<0.02). The treatment of HL-60 cells with 1, 25-(OH)2D3 in a mixture of 5% normal plus 5% uremic serum caused cell differentiation to an extent similar to that in 10% uremic serum, which suggests the presence of a substance(s) having 1, 25-(OH)2D3-inhibitory activity in the uremic serum. Exposure of HL-60 cells to uremic serum significantly impaired their responsiveness to 1, 25-(OH)2D3 as assessed by the induction of the cell's ability to hydroxylate the C-24 position of 1, 25-(OH)2 [3H] D3. The mechanism by which uremic serum confers an impaired cellular response to 1, 25-(OH)2D3 seemed to be due, in part, to a decrease in 1, 25-(OH)2D3 receptor levels. A significant positive correlation was observed between intracellular cAMP levels and 1, 25-(OH)2D3-induced HL-60 cell maturation. In summary, the mechanism by which uremic serum confers 1, 25-(OH)2D3 resistance upon HL-60 cells seemed to be due to the presence of 1, 25-(OH)2D3-inhibitory activity in uremic serum, which may modulate cellular responsiveness to 1, 25-(OH)2D3 by such mechanisms as reducing 1, 25-(OH)2D3 receptor levels in the cells, in part through alteration in cAMP metabolism.
- 財団法人 学会誌刊行センターの論文
著者
-
Nishizawa Yoshiki
Second Department Of Internal Medicine Osaka City University Medical School
-
MORII HIROTOSHI
Second Department of Internal Medicine Osaka City University
-
INABA MASAAKI
Second Department of Internal Medicine, Osaka City University
-
INABA Masaaki
Second Department of Internal Medicine, Osaka City University Medical School
-
OKUNO Senji
Second Department of Internal Medicine, Osaka City University Medical School
-
KOYAMA Hidenori
Second Department of Internal Medicine, Osaka City University Medical School
関連論文
- -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
- Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
- Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
- Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
- Significance of the Parathyroid Hormone-related Protein Expression in Breast Carcinoma
- Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
- Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
- Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
- A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
- Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
- Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
- Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
- A Case Report of Turner's Sydrome with Ring X Chromosome
- Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
- Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet:Changes in High Density Lipoprotein
- Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients during Intermittent Oral High-dose 1, 25(OH)2D3 Treatment
- Obesity as a Determinant of Regional Bone Mineral Density
- Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
- Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
- Cardiac Function and Exercise Capacity of Diabetic Patients
- Calcium Metabolism in Diabetes Mellitus
- Nutrition and Renal Osteodystrophy